Cargando…
Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade
Death Receptor 5 (DR5) is known to be an important anti-cancer drug target. TRAIL is a natural ligand of DR5, but its drug action is limited because of several factors. A few agonistic ligands were identified as TRAIL-DR5 axis modulators, which enhance the cellular apoptosis. Literature suggest that...
Autores principales: | Das, Sarita, Tripathi, Neha, Preet, Ranjan, Siddharth, Sumit, Nayak, Anmada, Bharatam, Prasad V., Kundu, Chanakya Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352116/ https://www.ncbi.nlm.nih.gov/pubmed/27542249 http://dx.doi.org/10.18632/oncotarget.11335 |
Ejemplares similares
-
Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1
por: Nayak, Anmada, et al.
Publicado: (2016) -
Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage
por: Siddharth, Sumit, et al.
Publicado: (2017) -
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020) -
Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947) -
Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943)